{"id":"heparin-clopidogrel-aspirin","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Thrombocytopenia"},{"rate":null,"effect":"Gastrointestinal hemorrhage"},{"rate":null,"effect":"Intracranial hemorrhage"}]},"_chembl":{"chemblId":"CHEMBL1771","moleculeType":"Small molecule","molecularWeight":"321.83"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Heparin is an anticoagulant that potentiates antithrombin III to inactivate thrombin and factor Xa, preventing fibrin formation. Aspirin irreversibly inhibits cyclooxygenase to reduce thromboxane A2 and platelet aggregation. Clopidogrel is a P2Y12 receptor antagonist that blocks ADP-mediated platelet activation. Together, these agents provide synergistic antithrombotic effects through complementary mechanisms.","oneSentence":"This triple antiplatelet and anticoagulant combination inhibits blood clot formation through multiple pathways: heparin blocks thrombin and factor Xa, while clopidogrel and aspirin inhibit platelet aggregation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:47:28.894Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Prevention of thrombotic events in high-risk cardiovascular patients"}]},"trialDetails":[{"nctId":"NCT05531474","phase":"NA","title":"Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2020-11-02","conditions":"Cardiovascular Complication, Bariatric Surgery Candidate","enrollment":200},{"nctId":"NCT05707442","phase":"PHASE3","title":"Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-16","conditions":"Idiopathic Intracranial Hypotension, Venous Sinus Stenosis","enrollment":74},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT00508924","phase":"PHASE2","title":"Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2005-08","conditions":"Coronary Artery Disease, Angina, Unstable","enrollment":140},{"nctId":"NCT06712004","phase":"PHASE2","title":"A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2025-02-10","conditions":"Ischemic Stroke, Acute, Ischemic Stroke, Cerebral Infarction","enrollment":40},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04261478","phase":"NA","title":"Endovascular Acute Stroke Intervention - Tandem OCclusion Trial","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2020-08-31","conditions":"Stroke, Acute, Carotid Stenosis, Carotid Artery Diseases","enrollment":458},{"nctId":"NCT02835534","phase":"PHASE4","title":"The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI","status":"COMPLETED","sponsor":"CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2016-05","conditions":"Acute ST Elevation Myocardial Infarction","enrollment":818},{"nctId":"NCT05007054","phase":"","title":"Long-Term Outcomes in Patients With Three-Vessel Disease","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Dalian Medical University","startDate":"2021-05-01","conditions":"Three Vessel Coronary Disease","enrollment":4300},{"nctId":"NCT02086019","phase":"NA","title":"Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes","status":"COMPLETED","sponsor":"Brighton and Sussex University Hospitals NHS Trust","startDate":"2014-05-01","conditions":"Acute Coronary Syndromes","enrollment":250},{"nctId":"NCT02618837","phase":"PHASE4","title":"Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2015-12-14","conditions":"Unstable Angina or Non ST Elevated Myocardial Infarction","enrollment":2520},{"nctId":"NCT04588571","phase":"NA","title":"Efficacy and Safety Comparison of the Open Surgical and Endovascular Methods for the Treatment of Long Atherosclerotic Lesions of the Femoral-popliteal Segment Above the Knee, TASC II, Type D.","status":"UNKNOWN","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2020-10-01","conditions":"Atherosclerosis, Ischemia Limb, Superficial Femoral Artery Occlusion","enrollment":110},{"nctId":"NCT04590131","phase":"NA","title":"Efficacy and Safety Comparison of the Endovascular and the Hybrid Methods for the Treatment of Prolonged Atherosclerotic Lesions of the Femoral-popliteal Segment Above the Knee, TASC II, Type D","status":"UNKNOWN","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2020-11-01","conditions":"Atherosclerosis, Ischemia Limb, Superficial Femoral Artery Occlusion","enrollment":100},{"nctId":"NCT04518735","phase":"","title":"Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2020-04-01","conditions":"Covid19","enrollment":1707},{"nctId":"NCT03867461","phase":"NA","title":"The Effects of MAP and EtCO2 on Venous Sinus Pressures","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-06-20","conditions":"Idiopathic Intracranial Hypertension","enrollment":8},{"nctId":"NCT00669149","phase":"PHASE4","title":"Anticoagulant Treatments and Percutaneous Coronary Angioplasty","status":"TERMINATED","sponsor":"Centre Hospitalier de PAU","startDate":"2008-06","conditions":"Coronary Artery Disease","enrollment":99},{"nctId":"NCT02681016","phase":"NA","title":"Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2015-03","conditions":"Ischemic Heart Disease, Coronary Atherosclerosis, Coronary Artery Disease","enrollment":610},{"nctId":"NCT03328156","phase":"","title":"Erectile Dysfunction After Percutaneous Coronary Intervention Versus the Thrombolytic Therapy in Acute ST Elevation Myocardial Infarction","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-10-30","conditions":"STEMI","enrollment":300},{"nctId":"NCT02492230","phase":"PHASE2","title":"Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI","status":"UNKNOWN","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2015-05","conditions":"Myocardial Infarction","enrollment":50},{"nctId":"NCT02777359","phase":"PHASE2","title":"Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2017-01","conditions":"Patent Foramen Ovale","enrollment":100},{"nctId":"NCT02722720","phase":"NA","title":"Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2015-09","conditions":"Carotid Atherosclerosis, Carotid Stenosis, Ischemic Attack","enrollment":200},{"nctId":"NCT01241903","phase":"PHASE1","title":"Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions","status":"COMPLETED","sponsor":"Susan Smyth","startDate":"2011-06","conditions":"Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary, Hydroxymethylglutaryl-CoA Reductase Inhibitors","enrollment":54},{"nctId":"NCT02590471","phase":"PHASE4","title":"Pilot Prospective Study of Two Methods of Revascularization of the Femoral Artery (SFA): Stenting in the SFA, and Stenting of the SFA, Supplemented by Fasciotomy in Hunter Channel.","status":"UNKNOWN","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2015-10","conditions":"Atherosclerosis of the Peripheral Artery","enrollment":50},{"nctId":"NCT02893280","phase":"","title":"Acute Coronary Syndrome Sri Lanka Audit Project","status":"WITHDRAWN","sponsor":"University of Colombo","startDate":"2015-04","conditions":"Acute Coronary Syndrome, Unstable Angina, Non ST Elevation Myocardial Infarction","enrollment":""},{"nctId":"NCT02769650","phase":"NA","title":"Stress-MRI Assessment After Right Coronary Artery CTO Recanalization","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2010-10","conditions":"Ischemic Heart Disease, Coronary Atherosclerosis, Coronary Artery Disease","enrollment":72},{"nctId":"NCT02708329","phase":"NA","title":"T-provisional Stenting vs Mini-Crush in Chronic Total Occlusions (CTO)","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2011-01","conditions":"Ischemic Heart Disease, Coronary Atherosclerosis, Coronary Artery Disease","enrollment":146},{"nctId":"NCT00494156","phase":"NA","title":"Anticoagulation in Blunt Cerebrovascular Injuries","status":"WITHDRAWN","sponsor":"C. Clay Cothren, MD","startDate":"2003-07","conditions":"Carotid Artery Injury, Vertebral Artery Injury","enrollment":""},{"nctId":"NCT00238667","phase":"PHASE3","title":"To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection","status":"COMPLETED","sponsor":"St George's, University of London","startDate":"2005-11","conditions":"Cervical Artery Dissection, Carotid Artery Dissection, Vertebral Artery Dissection","enrollment":250},{"nctId":"NCT02310191","phase":"","title":"Correlation Between Laboratory Markers and Origin of New Brain Ischemic Lesions After Carotid Stenting","status":"COMPLETED","sponsor":"University Hospital Ostrava","startDate":"2012-07","conditions":"Carotid Stenosis, Brain Ischemia, Laboratory Problem","enrollment":81},{"nctId":"NCT00715455","phase":"PHASE2","title":"Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI","status":"COMPLETED","sponsor":"Regado Biosciences, Inc.","startDate":"2007-10","conditions":"Coronary Artery Disease","enrollment":26},{"nctId":"NCT00683111","phase":"PHASE4","title":"Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease","status":"COMPLETED","sponsor":"Ruttonjee Hospital","startDate":"2008-07","conditions":"Acute Coronary Syndrome, Acute Myocardial Infarction","enrollment":500},{"nctId":"NCT00398463","phase":"PHASE4","title":"Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance","status":"COMPLETED","sponsor":"Università degli Studi di Ferrara","startDate":"2006-05","conditions":"Angioplasty, Transluminal, Percutaneous Coronary","enrollment":263},{"nctId":"NCT01157455","phase":"PHASE4","title":"A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization","status":"UNKNOWN","sponsor":"CCRF Consulting Co., Ltd.","startDate":"2010-05","conditions":"Coronary Artery Diseases","enrollment":1900},{"nctId":"NCT00905008","phase":"","title":"Long-Term Safety of Drug Eluting Stents in the \"Real World\" (FReIburger STent Registry)","status":"UNKNOWN","sponsor":"University Hospital Freiburg","startDate":"2006-10","conditions":"Stent Thrombosis","enrollment":1502},{"nctId":"NCT00493584","phase":"NA","title":"Acute Balloon Angioplasty vs. Traditional Early Invasive Treatment of Non-ST-Elevation Myocardial Infarction","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2008-03","conditions":"Myocardial Infarction","enrollment":14},{"nctId":"NCT00759629","phase":"PHASE4","title":"Beyond 12 Hours Reperfusion AlternatiVe Evaluation Trial","status":"COMPLETED","sponsor":"Deutsches Herzzentrum Muenchen","startDate":"2001-05","conditions":"Myocardial Infarction","enrollment":365},{"nctId":"NCT00611169","phase":"PHASE4","title":"The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2006-01","conditions":"Acute Myocardial Infarction","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["héparine Choay Plavix Kardégic"],"phase":"marketed","status":"active","brandName":"heparin + clopidogrel + aspirin","genericName":"heparin + clopidogrel + aspirin","companyName":"Centre Hospitalier de PAU","companyId":"centre-hospitalier-de-pau","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This triple antiplatelet and anticoagulant combination inhibits blood clot formation through multiple pathways: heparin blocks thrombin and factor Xa, while clopidogrel and aspirin inhibit platelet aggregation. Used for Acute coronary syndrome, Prevention of thrombotic events in high-risk cardiovascular patients.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}